The Current Ratio as of September 2024 (TTM) for Enzon Pharmaceuticals, Inc. (ENZN) is 113.75

According to Enzon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 113.75. This represents a change of 31.49% compared to the average of 86.51 of the last 4 quarters.

Enzon Pharmaceuticals, Inc. (ENZN) Historical Current Ratio (quarterly & annually)

How has ENZN Current Ratio performed in the past?

The mean historical Current Ratio of Enzon Pharmaceuticals, Inc. over the last ten years is 37.17. The current 113.75 Current Ratio has changed 30.50% with respect to the historical average. Over the past ten years (40 quarters), ENZN's Current Ratio was at its highest in in the September 2021 quarter at 127.22. The Current Ratio was at its lowest in in the June 2015 quarter at 1.76.

Enzon Pharmaceuticals, Inc. (ENZN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Enzon Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Enzon Pharmaceuticals, Inc. (ENZN) Average Current Ratio

How has ENZN Current Ratio performed in the past?

The current Current Ratio of Enzon Pharmaceuticals, Inc. (ENZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Enzon Pharmaceuticals, Inc. (ENZN) Current Ratio vs. Peers

How is ENZN’s Current Ratio compared to its peers?

Enzon Pharmaceuticals, Inc.’s Current Ratio is greater than PMV Pharmaceuticals, Inc. (19.22), greater than NewAmsterdam Pharma Company N.V. (9.83), greater than Tempest Therapeutics, Inc. (2.17), greater than IO Biotech, Inc. (7.84), less than Molecular Pharmacology (USA), Ltd. (0), greater than Curative Biotechnology, Inc. (0.07), less than Kineta, Inc. (0), greater than OncoVista Innovative Therapies, Inc. (0.14), less than Neurobiological Technologies, Inc. (0), less than Polydex Pharmaceuticals Limited (0), less than Cyclacel Pharmaceuticals, Inc. (0), greater than Living Cell Technologies Limited (1.26), greater than MultiCell Technologies, Inc. (1.07), greater than Institute of Biomedical Research Corp. (17.89), greater than Health Sciences Group, Inc. (0.11), greater than Mymetics Corporation (0), less than Eliem Therapeutics, Inc. (0), greater than Molecular Partners AG (0.00), greater than Opthea Limited (60.41), greater than PureTech Health plc (14.58), greater than Acrivon Therapeutics, Inc. Common Stock (2.94), greater than null (3.68), greater than null (16.16),

Build a custom stock screener for Enzon Pharmaceuticals, Inc. (ENZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enzon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enzon Pharmaceuticals, Inc. (ENZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enzon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.